COVID-19 will test medical supply stocks
“In the matter of a week or two…I think we’ll get a feel for whether or not we really have enough of the supplies that it takes,” said Dr. Anthony Fauci.
Related Articles
Physicians Own Less Than Half of US Practices; Federal Agencies Want Outside Input
A new report on trends in medical practice ownership came amid increased federal scrutiny of consolidation and the role of private equity.
Too Little Sleep Raises Health Risks for Teens With T1D
“Sleep may be an important and novel target for improving health in individuals with T1D, particularly when initiated in adolescence or early in diabetes.”
4 Years In, a Sobering Look at Long COVID Progress
Long COVID is still a disease diagnosed by figuring out what a patient does not have. Symptom management is the only treatment now.
Impact of Ketogenic and Low-Glycemic Diets on Inflammatory Skin Conditions
Diet plays an emerging role in dermatologic therapy. The ketogenic and low-glycemic diets have potential anti-inflammatory and metabolic effects, making them attractive for treating inflammatory…
Meta-analysis Identifies Atopic Dermatitis as Potential Risk Factor for Headache Disorder or Migraine
Key clinical point: Atopic dermatitis (AD) is significantly associated with a higher ri
IV Ketamine Promising for Severe Refractory Headache in Children
Overall, the treatment was “safe and well tolerated.”
Empowering ICU physicians in MCS critical care
Fellowship programs can aid in training cardiogenic shock.
What’s Driving the Higher Breast Cancer Death Rate in Black Women?
New research suggests that racial disparities in breast cancer are driven by more than socioeconomic factors.
Eradicating uncertainty: A review of Pseudomonas aeruginosa eradication in bronchiectasis
Ideal treatment to eliminate NCFB is unknown, though studies have pointed to inhaled tobramycin for chronic P. aeruginosa infections.